PALISADE CAPITAL MANAGEMENT, LP
Position in EBS — Emergent BioSolutions Inc.
CIK 1009006
FORT LEE, NJ
Position in EBS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,316,194
-$5,654,786 QoQ
Shares Held
515,059
-57.1% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#23
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $4,316,194 across 1 Drug Manufacturers - Specialty & Generic name. EBS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EBS |
Emergent BioSolutions Inc.
This page
|
515,059 | $4,316,194 |
All Filings in EBS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,316,194 | 515,059 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,970,980 | 1,201,323 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,644,867 | 1,265,766 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,577,487 | 1,426,019 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,016,462 | 1,099,759 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,548,122 | 1,141,589 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,974,277 | 938,732 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,261,915 | 749,930 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,095,113 | 453,829 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,167,969 | 461,648 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,080,988 | 450,412 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,731,705 | 509,325 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,957,372 | 538,418 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,323,703 | 513,871 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $5,924,746 | 501,672 | Shares | Sole | 2023-03-24 | |
| 2022-09-30 | $11,061,499 | 526,989 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,571,123 | 566,080 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $23,010,393 | 560,409 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $25,428,080 | 584,957 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $32,218,242 | 643,464 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $37,950,215 | 602,480 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $58,158,779 | 625,969 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $51,879,206 | 579,009 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $44,315,653 | 428,875 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $29,263,554 | 370,050 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $11,606,831 | 200,602 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||